Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript
X4 Pharmaceuticals, Inc (XFOR) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "X4 Pharmaceuticals Reports Second-Quarter 2023 Financial Results, Provides Corporate Updates, and Reports Emerging Data from"
08/03/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
06/01/2023 8-K Regulation FD Disclosure  Interactive Data
05/16/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events ...
Docs: "X4 PHARMACEUTICALS, INC. FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK",
"SECURITIES PURCHASE AGREEMENT",
"REGISTRATION RIGHTS AGREEMENT",
"X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market",
"X4 Pharmaceuticals Announces Positive Phase 3 Results Showing Mavorixafor Reduced the Rate, Severity, and Duration of Infections vs. Placebo in Participants Diagnosed with WHIM Syndrome",
"01 02 03 04 05 06"
05/04/2023 8-K Quarterly results
05/04/2023 8-K Quarterly results
05/04/2023 8-K Quarterly results
Docs: "X4 Pharmaceuticals Reports First-Quarter 2023 Financial Results and Provides Corporate Update"
03/21/2023 8-K Regulation FD Disclosure  Interactive Data
03/21/2023 8-K Quarterly results
Docs: "X4 Pharmaceuticals Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update"
03/10/2023 8-K Other Events  Interactive Data
01/06/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
01/05/2023 8-K Regulation FD Disclosure  Interactive Data
12/23/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "X4 Pharmaceuticals, Inc. Amended and Restated 2019 Inducement Equity Incentive Plan",
"X4 Pharmaceuticals, Inc. Amended and Restated 2019 Inducement Equity Incentive Plan"
12/09/2022 8-K Quarterly results
11/29/2022 8-K Quarterly results
11/09/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
10/04/2022 8-K Regulation FD Disclosure, Other Events  Interactive Data
Docs: "C H R O N IC N E U T R O P E N IC D IS O R D E R S"
09/27/2022 8-K Regulation FD Disclosure, Other Events  Interactive Data
Docs: "X4 Pharmaceuticals Announces New Positive Phase 1b Data Supporting",
"01 02 03 04 05 06"
09/01/2022 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "3.1 RESTATED CERTIFICATE OF INCORPORATION OF X4 PHARMACEUTICALS, INC."
08/05/2022 8-K Investor presentation
Docs: "Corporate Overview August 2022 2 Forward-Looking Statements This"
08/04/2022 8-K Quarterly results
Docs: "X4 Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update"
07/29/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
07/01/2022 8-K Quarterly results
06/07/2022 8-K Quarterly results
05/20/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
Docs: "X4 Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update"
03/17/2022 8-K Quarterly results
Docs: "X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Provides Corporate Update"
03/03/2022 8-K Quarterly results
02/09/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "AMENDMENT NO. 3 TO"
01/26/2022 8-K/A Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events  Interactive Data
01/25/2022 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events  Interactive Data
01/14/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Cooley LLP 55 Hudson Yards, New York, New York 10001-2157 Telephone: +1 212 479 6000, Facsimile: +1 212 479 6275",
"PURCHASE AGREEMENT",
"REGISTRATION RIGHTS AGREEMENT"
01/14/2022 8-K Termination of a Material Definitive Agreement  Interactive Data
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy